Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin-Reference-Cited by-同舟云学术

Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin

Published:2012-10 Issue:4 Volume:66 Page:332-342
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Matijašić Mario,Munić Kos Vesna,Nujić Krunoslav,Čužić Snježana,Padovan Jasna,Kragol Goran,Alihodžić Sulejman,Mildner Boris,Verbanac Donatella,Eraković Haber Vesna

Publisher

Elsevier BV

Subject

Pharmacology

Reference44 articles.

1. Anti-inflammatory effects of macrolide antibiotics;Culic;European Journal of Pharmacology,2001

2. Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro;Marjanovic;Pharmacological Research,2011

3. Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties;Polancec;Journal of Leukocyte Biology,2012

4. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action;Shinkai;Pharmacology and Therapeutics,2008

5. Azithromycin distinctively modulates classical activation of human monocytes in vitro;Vrancic;British Journal of Pharmacology,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational pathology in drug discovery;Frontiers in Pharmacology;2024-06-10

2. Antimicrobial macrozones interact with biological macromolecules via two-site binding mode of action: Fluorimetric, NMR and docking studies;Bioorganic Chemistry;2024-06

3. Modification of Azithromycin to Mitigate its Arrest of Autophagy;2024-04-26

4. Azithromycin alters Colony Stimulating Factor-1R (CSF-1R) expression and functional output of murine bone marrow-derived macrophages: A novel report;International Immunopharmacology;2023-10

5. A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer;Cancer Research Communications;2023-06-05